aluates Reports

$ 0.0

Automative

Global Irritable Bowel Syndrome (IBS) Market Research Report 2026

Published Date: 2026-01-15

Report Code: QYRE-Auto-37T9015

Global Irritable Bowel Syndrome IBS Market Size Status and Forecast 2022

BUY CHAPTERS

Global Irritable Bowel Syndrome (IBS) Market Research Report 2026

Code: QYRE-Auto-37T9015

Report

2026-01-15

Pages:103

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Takeda

Sucampo Pharmaceuticals (Mallinckrodt)

Sebela Pharmaceuticals Inc

Astellas Pharmaceuticals

Allergan plc

Bausch Health

Irritable Bowel Syndrome (IBS) Market Size

The global Irritable Bowel Syndrome (IBS) market was valued at US$ 7096 million in 2025 and is anticipated to reach US$ 18630 million by 2032, at a CAGR of 15.0% from 2026 to 2032.

Irritable Bowel Syndrome (IBS) Market

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.

This report delivers a comprehensive overview of the global Irritable Bowel Syndrome (IBS) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Irritable Bowel Syndrome (IBS). The Irritable Bowel Syndrome (IBS) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Irritable Bowel Syndrome (IBS) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Irritable Bowel Syndrome (IBS) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Irritable Bowel Syndrome (IBS) Market Report

Report Metric	Details
Report Name	Irritable Bowel Syndrome (IBS) Market
Accounted market size in 2025	US$ 7096 million
Forecasted market size in 2032	US$ 18630 million
CAGR	15.0%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	IBS-D Drug IBS-C Drug Others
Segment by Application	Women Men
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bausch Health, Allergan, Takeda, Sucampo Pharmaceuticals (Mallinckrodt), Sebela Pharmaceuticals Inc, Astellas Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Irritable Bowel Syndrome (IBS) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Irritable Bowel Syndrome (IBS) Market growing?

Ans: The Irritable Bowel Syndrome (IBS) Market witnessing a CAGR of 15.0% during the forecast period 2026-2032.

What is the Irritable Bowel Syndrome (IBS) Market size in 2032?

Ans: The Irritable Bowel Syndrome (IBS) Market size in 2032 will be US$ 18630 million.

What is the Irritable Bowel Syndrome (IBS) Market share by region?

Ans: North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%.

What is the market share of major companies in Irritable Bowel Syndrome (IBS) Market?

Ans: Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.

Who are the main players in the Irritable Bowel Syndrome (IBS) Market report?

Ans: The main players in the Irritable Bowel Syndrome (IBS) Market are Bausch Health, Allergan, Takeda, Sucampo Pharmaceuticals (Mallinckrodt), Sebela Pharmaceuticals Inc, Astellas Pharmaceuticals

What are the Application segmentation covered in the Irritable Bowel Syndrome (IBS) Market report?

Ans: The Applications covered in the Irritable Bowel Syndrome (IBS) Market report are Women, Men

What are the Type segmentation covered in the Irritable Bowel Syndrome (IBS) Market report?

Ans: The Types covered in the Irritable Bowel Syndrome (IBS) Market report are IBS-D Drug, IBS-C Drug, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 IBS-D Drug

1.2.3 IBS-C Drug

1.2.4 Others

1.3 Market by Application

1.3.1 Global Irritable Bowel Syndrome (IBS) Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Women

1.3.3 Men

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Irritable Bowel Syndrome (IBS) Market Perspective (2021–2032)

2.2 Global Irritable Bowel Syndrome (IBS) Growth Trends by Region

2.2.1 Global Irritable Bowel Syndrome (IBS) Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Irritable Bowel Syndrome (IBS) Historic Market Size by Region (2021–2026)

2.2.3 Irritable Bowel Syndrome (IBS) Forecasted Market Size by Region (2027–2032)

2.3 Irritable Bowel Syndrome (IBS) Market Dynamics

2.3.1 Irritable Bowel Syndrome (IBS) Industry Trends

2.3.2 Irritable Bowel Syndrome (IBS) Market Drivers

2.3.3 Irritable Bowel Syndrome (IBS) Market Challenges

2.3.4 Irritable Bowel Syndrome (IBS) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue

3.1.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue (2021–2026)

3.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2021–2026)

3.2 Global Top Irritable Bowel Syndrome (IBS) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Irritable Bowel Syndrome (IBS) Revenue

3.4 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio

3.4.1 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Revenue in 2025

3.5 Global Key Players of Irritable Bowel Syndrome (IBS) Head Offices and Areas Served

3.6 Global Key Players of Irritable Bowel Syndrome (IBS), Products and Applications

3.7 Global Key Players of Irritable Bowel Syndrome (IBS), Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Irritable Bowel Syndrome (IBS) Breakdown Data by Type

4.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Type (2021–2026)

4.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2027–2032)

5 Irritable Bowel Syndrome (IBS) Breakdown Data by Application

5.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Application (2021–2026)

5.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Irritable Bowel Syndrome (IBS) Market Size (2021–2032)

6.2 North America Irritable Bowel Syndrome (IBS) Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2021–2026)

6.4 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Irritable Bowel Syndrome (IBS) Market Size (2021–2032)

7.2 Europe Irritable Bowel Syndrome (IBS) Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2021–2026)

7.4 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size (2021–2032)

8.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2021–2026)

8.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Irritable Bowel Syndrome (IBS) Market Size (2021–2032)

9.2 Latin America Irritable Bowel Syndrome (IBS) Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2021–2026)

9.4 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size (2021–2032)

10.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2021–2026)

10.4 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bausch Health

11.1.1 Bausch Health Company Details

11.1.2 Bausch Health Business Overview

11.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Introduction

11.1.4 Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)

11.1.5 Bausch Health Recent Development

11.2 Allergan

11.2.1 Allergan Company Details

11.2.2 Allergan Business Overview

11.2.3 Allergan Irritable Bowel Syndrome (IBS) Introduction

11.2.4 Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)

11.2.5 Allergan Recent Development

11.3 Takeda

11.3.1 Takeda Company Details

11.3.2 Takeda Business Overview

11.3.3 Takeda Irritable Bowel Syndrome (IBS) Introduction

11.3.4 Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)

11.3.5 Takeda Recent Development

11.4 Sucampo Pharmaceuticals (Mallinckrodt)

11.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Details

11.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview

11.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Introduction

11.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)

11.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Development

11.5 Sebela Pharmaceuticals Inc

11.5.1 Sebela Pharmaceuticals Inc Company Details

11.5.2 Sebela Pharmaceuticals Inc Business Overview

11.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Introduction

11.5.4 Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)

11.5.5 Sebela Pharmaceuticals Inc Recent Development

11.6 Astellas Pharmaceuticals

11.6.1 Astellas Pharmaceuticals Company Details

11.6.2 Astellas Pharmaceuticals Business Overview

11.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction

11.6.4 Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)

11.6.5 Astellas Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Takeda

Sucampo Pharmaceuticals (Mallinckrodt)

Sebela Pharmaceuticals Inc

Astellas Pharmaceuticals

Allergan plc

Bausch Health

List of Tables

Table 1. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of IBS-D Drug

Table 3. Key Players of IBS-C Drug

Table 4. Key Players of Others

Table 5. Global Irritable Bowel Syndrome (IBS) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Irritable Bowel Syndrome (IBS) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Irritable Bowel Syndrome (IBS) Market Size by Region (US$ Million), 2021–2026

Table 8. Global Irritable Bowel Syndrome (IBS) Market Share by Region (2021–2026)

Table 9. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Irritable Bowel Syndrome (IBS) Market Share by Region (2027–2032)

Table 11. Irritable Bowel Syndrome (IBS) Market Trends

Table 12. Irritable Bowel Syndrome (IBS) Market Drivers

Table 13. Irritable Bowel Syndrome (IBS) Market Challenges

Table 14. Irritable Bowel Syndrome (IBS) Market Restraints

Table 15. Global Irritable Bowel Syndrome (IBS) Revenue by Players (US$ Million), 2021–2026

Table 16. Global Irritable Bowel Syndrome (IBS) Market Share by Players (2021–2026)

Table 17. Global Top Irritable Bowel Syndrome (IBS) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Irritable Bowel Syndrome (IBS) Revenue, 2025

Table 18. Ranking of Global Top Irritable Bowel Syndrome (IBS) Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Irritable Bowel Syndrome (IBS) Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Irritable Bowel Syndrome (IBS), Headquarters and Area Served

Table 21. Global Key Players of Irritable Bowel Syndrome (IBS), Products and Applications

Table 22. Global Key Players of Irritable Bowel Syndrome (IBS), Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Irritable Bowel Syndrome (IBS) Market Size by Type (US$ Million), 2021–2026

Table 25. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2021–2026)

Table 26. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2027–2032)

Table 28. Global Irritable Bowel Syndrome (IBS) Market Size by Application (US$ Million), 2021–2026

Table 29. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2021–2026)

Table 30. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2027–2032)

Table 32. North America Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2021–2026

Table 34. North America Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2027–2032

Table 47. Bausch Health Company Details

Table 48. Bausch Health Business Overview

Table 49. Bausch Health Irritable Bowel Syndrome (IBS) Product

Table 50. Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026

Table 51. Bausch Health Recent Development

Table 52. Allergan Company Details

Table 53. Allergan Business Overview

Table 54. Allergan Irritable Bowel Syndrome (IBS) Product

Table 55. Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026

Table 56. Allergan Recent Development

Table 57. Takeda Company Details

Table 58. Takeda Business Overview

Table 59. Takeda Irritable Bowel Syndrome (IBS) Product

Table 60. Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026

Table 61. Takeda Recent Development

Table 62. Sucampo Pharmaceuticals (Mallinckrodt) Company Details

Table 63. Sucampo Pharmaceuticals (Mallinckrodt) Business Overview

Table 64. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product

Table 65. Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026

Table 66. Sucampo Pharmaceuticals (Mallinckrodt) Recent Development

Table 67. Sebela Pharmaceuticals Inc Company Details

Table 68. Sebela Pharmaceuticals Inc Business Overview

Table 69. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product

Table 70. Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026

Table 71. Sebela Pharmaceuticals Inc Recent Development

Table 72. Astellas Pharmaceuticals Company Details

Table 73. Astellas Pharmaceuticals Business Overview

Table 74. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product

Table 75. Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026

Table 76. Astellas Pharmaceuticals Recent Development

Table 77. Research Programs/Design for This Report

Table 78. Key Data Information from Secondary Sources

Table 79. Key Data Information from Primary Sources

Table 80. Authors List of This Report

List of Figures

Figure 1. Irritable Bowel Syndrome (IBS) Picture

Figure 2. Global Irritable Bowel Syndrome (IBS) Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Irritable Bowel Syndrome (IBS) Market Share by Type: 2025 vs 2032

Figure 4. IBS-D Drug Features

Figure 5. IBS-C Drug Features

Figure 6. Others Features

Figure 7. Global Irritable Bowel Syndrome (IBS) Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2025 vs 2032

Figure 9. Women Case Studies

Figure 10. Men Case Studies

Figure 11. Irritable Bowel Syndrome (IBS) Report Years Considered

Figure 12. Global Irritable Bowel Syndrome (IBS) Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Irritable Bowel Syndrome (IBS) Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Irritable Bowel Syndrome (IBS) Market Share by Region: 2025 vs 2032

Figure 15. Global Irritable Bowel Syndrome (IBS) Market Share by Players in 2025

Figure 16. Global Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome (IBS) Revenue in 2025

Figure 18. North America Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Irritable Bowel Syndrome (IBS) Market Share by Country (2021–2032)

Figure 20. United States Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Irritable Bowel Syndrome (IBS) Market Share by Country (2021–2032)

Figure 24. Germany Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Share by Region (2021–2032)

Figure 32. China Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Irritable Bowel Syndrome (IBS) Market Share by Country (2021–2032)

Figure 40. Mexico Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Country (2021–2032)

Figure 44. Israel Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)

Figure 48. Allergan Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)

Figure 49. Takeda Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)

Figure 50. Sucampo Pharmaceuticals (Mallinckrodt) Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)

Figure 51. Sebela Pharmaceuticals Inc Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)

Figure 52. Astellas Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Irritable Bowel Syndrome IBS Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Irritable Bowel Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Irritable Bowel Syndrome Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Irritable Bowel Syndrome with Diarrhea IBS D Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Irritable Bowel Syndrome Drug Market Research Report 2024

Global Gastrointestinal Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Irritable Bowel Syndrome Medication Market Research Report 2025

Global Digestive Drugs Market Insights Forecast to 2030

Global IBS Probiotic Supplement Market Research Report 2024

Global IBS C Drugs Market Research Report 2024

Global Irritable Bowel Syndrome with Constipation Drugs Market Research Report 2024

Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Idiopathic Constipation Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Short Bowel Syndrome SBS Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Digestive Distress Treatment Market Research Report 2024

Global Gastrointestinal Therapeutics Market Research Report 2024

Global Gastrointestinal Drugs Market Research Report 2025

Global IBS Implant Market Research Report 2024

Global Healthcare Bowel Management Systems Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions